Core Insights - Aging is characterized by the gradual loss of stability in the internal environment of organisms, leading to a decline in physiological functions and overall health, which increases the incidence of various chronic diseases [3] - Cellular senescence is a key feature and driving factor of aging, with the burden of senescent cells increasing with age, closely related to almost all other aging markers [3] - Selective clearance of senescent cells is emerging as a promising therapeutic intervention to extend healthspan and treat age-related diseases [3] Research Findings - A new study published in Cell Press Blue identifies conjugated polyunsaturated fatty acids, particularly α-eleostearic acid and its methyl ester derivatives, as senolytics that exploit the ferroptotic vulnerability in senescent cells [4][6] - These conjugated polyunsaturated fatty acids can effectively embed into cell membranes and selectively induce ferroptosis in senescent cells due to their elevated iron levels and lipid peroxidation characteristics, rather than apoptosis or necrosis [6] - The study reveals key targets in the ferroptosis pathway, including ACSL4, LPCAT3, and ALOX15, which are crucial for the lipid-induced clearance of senescent cells [6] Implications - The findings establish conjugated polyunsaturated fatty acids as inducers of ferroptosis in senescent cells, confirming ferroptosis as a targetable vulnerability in aging cells [8] - The research suggests that these lipid senolytics can reduce tissue aging in elderly mice and extend their healthspan [9]